Clinical value of controlling nutritional status scores in patients with hepatocellular carcinoma

QR Code

Clinical value of controlling nutritional status scores in patients with hepatocellular carcinoma

BackgroundNumerous studies have highlighted the significance of controlling nutritional status (CONUT) score in the prognosis of patients with hepatocellular carcinoma (HCC). However, the precise role of the CONUT scor in predicting HCC prognosis remains unclear. This study aimed to investigate the...

Full description

Saved in:

Bibliographic Details
Main Authors:	Rongqiang Liu, Lei Ji, Chenxuan Zhang, Jing Ye, Xinyi Li, Wangbin Ma, Jia Yu, Weixing Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Series:	Frontiers in Nutrition
Subjects:	controlling nutritional status score hepatocellular carcinoma prognosis survival meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fnut.2025.1598463/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Long-term results of liver transplantation for hepatocellular carcinoma
by: M. Sh. Khubutia, et al.
Published: (2018-08-01)

Predictive Value of Radiographic Tumor Burden Score in Hepatocellular Carcinoma Within Milan Criteria After Microwave Ablation: Implications for Long‐Term Outcomes and Treatment Planning
by: Xiaolin Liu, et al.
Published: (2025-05-01)

Functional Liver Imaging Score to Predict Clinically Significant PHLF for Hepatocellular Carcinoma After Resection
by: Zheng X, et al.
Published: (2025-07-01)

The incidence of malignant tumors in patients with liver cirrhosis and the impact of the development of hepatocellular carcinoma on the overall survival of patients with cirrhosis
by: Vladislav V. Petkau, et al.
Published: (2024-03-01)

A scoring model based on MRI features for predicting early recurrence after surgical resection of hepatocellular carcinoma
by: Yi-Jing Wang, et al.
Published: (2025-08-01)

Classification of microvascular invasion of hepatocellular carcinoma: Different standards, common goals: Letter to the editor on “Classification of microvascular invasion of hepatocellular carcinoma: Correlation with prognosis and magnetic resonance imaging”
by: Wei Chen, et al.
Published: (2025-07-01)

Deciphering adenosine signaling in hepatocellular carcinoma: Pathways, prognostic models, and therapeutic implications
by: Huihai Yang, et al.
Published: (2025-07-01)

A CT-Based Deep Learning Radiomics Scoring System for Predicting the Prognosis to Repeat TACE in Patients with Hepatocellular Carcinoma: A Multicenter Cohort Study
by: Dai Y, et al.
Published: (2025-07-01)

Transarterial Chemoembolization With or Without Systemic Therapy for Unresectable Hepatocellular Carcinoma: A Retrospective Comparative Study
by: Chengxiang Guo, et al.
Published: (2025-02-01)

The Naples Prognostic Score Exerts a Significant Impact on the Prognosis of Patients Diagnosed with External Auditory Canal Carcinoma After Surgery
by: Xu XL, et al.
Published: (2025-05-01)

Nomogram based on tumor burden score for prediction of prognosis of patients with hepatocellular carcinoma before hepatectomy
by: Qianru Xiao, et al.
Published: (2025-07-01)

The expression level and clinical significance of lncRNA X91348 in hepatocellular carcinoma
by: Zhen Zeng, et al.
Published: (2019-12-01)

Microwave ablation versus radiofrequency ablation for hepatocellular carcinoma: a propensity score matching and inverse probability weighting analysis
by: Wenlong Yang, et al.
Published: (2025-12-01)

Preoperative prognostic value of alfa-fetoprotein density in patients with hepatocellular carcinoma undergoing radiofrequency ablation
by: Bo-Wen Zhuang, et al.
Published: (2022-12-01)

Pan-Immune-Inflammation Value as a Prognostic Biomarker for Hepatocellular Carcinoma Patients Undergoing Hepatectomy
by: Fu H, et al.
Published: (2025-05-01)

Efficacy of therapies for intermediate-stage hepatocellular carcinoma: systematic review and network meta-analysis
by: Shaoqi Zong, et al.
Published: (2025-07-01)

FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma
by: Cheng‐Qian Zhong, et al.
Published: (2018-06-01)

Survival Benefit of Adjuvant Treatment with Huaier Granules Plus Lenvatinib in Hepatocellular Carcinoma Patients with Tumors Greater Than 5 cm After Radical Hepatectomy
by: Liu C, et al.
Published: (2025-07-01)

Roles of organic anion transporting polypeptides in hepatocellular carcinoma
by: Hubert Chen
Published: (2025-07-01)

Association of Survival with Radiologic-Pathologic Discordance in Patients with Hepatocellular Carcinoma: A Nationwide Cohort Study Based on the Primary Liver Cancer Registry in Korea
by: Woo Sun Rou, et al.
Published: (2025-07-01)

A novel vasculogenic mimicry-related nomogram predicts prognosis in hepatocellular carcinoma
by: Yun Zhong, et al.
Published: (2025-07-01)

Incidence of hepatocellular carcinoma in beta thalassemia: a systematic review and meta-analysis
by: Marcella Adisuhanto, et al.
Published: (2025-07-01)

Osteopenic occult vertebral fracture is associated with poor oncological outcome in patients with hepatocellular carcinoma after hepatic resection
by: Koichiro Haruki, et al.
Published: (2025-07-01)

Preoperative Hepatic Augmentation Versus Transarterial Chemoembolization for Hepatocellular Carcinoma With Insufficient Remnant Liver Volume: A Systematic Review and Meta‐Analysis
by: Wenjie Li, et al.
Published: (2025-07-01)

Molecular Subtyping of Hepatocellular Carcinoma via Lysosome-Related Genes for Prognosis and Therapy Prediction
by: Yao Y, et al.
Published: (2025-07-01)

Retrospective Multicentre Real-Life Study Evaluating the Efficacy of Atezolizumab Combined with Bevacizumab for the Treatment of Metastatic Hepatocellular Carcinoma: HIREAL Study
by: Barbe-Richaud JB, et al.
Published: (2025-07-01)

Integrated Multi-Omics Profiling Identifies PDZ-Binding Kinase (PBK) as a Novel Prognostic Biomarker in Hepatocellular Carcinoma
by: Zhang J, et al.
Published: (2025-07-01)

Role of cytokines in hepatocellular carcinoma
by: T. Aghayev, et al.
Published: (2022-11-01)

New prognostic model for liver transplantation outcomes in hepatocellular carcinoma
by: S. E. Voskanyan, et al.
Published: (2024-09-01)

BRAIN METASTASIS FROM HEPATOCELLULAR CARCINOMA: A RARE CASE
by: A. Kh. Bekyashev, et al.
Published: (2015-04-01)

Current Status and Future of Multidisciplinary Team in Hepatocellular Carcinoma
by: Jinbin CHEN, et al.
Published: (2025-06-01)

Transarterial chemoembolization combined with apatinib in the treatment of advanced hepatocellular carcinoma: a prospective, multi-center, real-world study (Ahend-HAP02)
by: Hang Yuan, et al.
Published: (2025-07-01)

Risk Factors of Non-Classic Radiation-Induced Liver Disease (ncRILD) After Intensity-Modulated Radiotherapy in Hepatocellular Carcinoma
by: Du YQ, et al.
Published: (2025-06-01)

Postoperative hepatitis B virus reactivation and its impact on survival in HBV-related hepatocellular carcinoma patients undergoing conversion therapy with interventional therapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors
by: Shaowei Xu, et al.
Published: (2025-07-01)

Application of Robotic Surgery in Hepatocellular Carcinoma
by: Li PH, et al.
Published: (2025-06-01)

Efficacy and safety of lenvatinib plus transarterial chemoembolization with or without programmed death-1 inhibitors in the treatment of intermediate or advanced hepatocellular carcinoma: a systematic review and meta-analysis
by: Yongfa Lei, et al.
Published: (2025-07-01)

Gut Microbiota and Hepatocellular Carcinoma: Metabolic Products and Immunotherapy Modulation
by: Kunmin Xiao, et al.
Published: (2025-05-01)

A Novel Nomogram for Prediction of Survival in Patients with Small Isolated Hepatocellular Carcinoma: A Population-Based and Externally Validated Study
by: Ziqiang Li, et al.
Published: (2025-12-01)

Liver Transplantation in the Treatment of Unresectable Hepatocellular Carcinoma in the Absence of Liver Cirrhosis
by: O. D. Olisov, et al.
Published: (2018-09-01)

Predicting recurrence and recurrence-free survival in initially unresectable hepatocellular carcinoma: a novel nomogram for patients undergoing conversion hepatectomy with lenvatinib, PD-1 inhibitor, and interventional therapy
by: Cheng Xu, et al.
Published: (2025-07-01)